Seven Critical Things To Consider Before Partnering With A CDMO

Partnering with Contract Development and Manufacturing Organizations (CDMOs) in the pharmaceutical industry offers numerous benefits, including cost reduction, access to expertise and technology, increased speed and efficiency, scalability, and the ability to focus on core competencies. However, there are several challenges that must be navigated.

Coordinating communication across multiple platforms can be challenging, especially with multiple individuals involved. Seamless information flow and keeping track of conversations are crucial for successful collaboration. Additionally, managing production capacity and demand fluctuations can be tricky, particularly when CDMOs have multiple clients. Careful planning is necessary to ensure adequate supply without excess inventory.

To address these challenges, effective communication, risk mitigation, and strategic planning are necessary. Assessing material needs, defining timelines, evaluating process development capabilities, analyzing analytical methods, and considering regulatory aspects are key steps in balancing supply and demand. By addressing these challenges and taking a comprehensive approach to partnering with CDMOs, pharmaceutical companies can enhance their collaborations and choose the right CDMO for their biologic projects.